Castle Biosciences, Inc.CSTLNASDAQ
Loading
Cash & Equivalents Over TimeStable
Percentile Rank50
3Y CAGR-1.7%
5Y CAGR-22.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-1.7%/yr
vs +128.9%/yr prior
5Y CAGR
-22.2%/yr
Recent acceleration
Acceleration
-130.6pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $116.73M | -2.5% |
| 2024 | $119.71M | +21.1% |
| 2023 | $98.84M | -19.6% |
| 2022 | $122.95M | -62.7% |
| 2021 | $329.63M | -19.6% |
| 2020 | $409.85M | +314.6% |
| 2019 | $98.84M | +2107.1% |
| 2018 | $4.48M | +269.5% |
| 2017 | $1.21M | - |